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Abstract: Objective. To evaluate the clinical effect of a probiotic 
mouthwash in reducing generalized marginal chronic gingivitis using positive 
and negative control groups. Methodology. Four-week study conducted in 
San Luis Potosí, Mexico, from January to March 2017. Participants were 
healthy, non-smokers with generalized marginal chronic gingivitis; age range 
18-45 years. Subjects were randomized and divided into three groups: Group 
A: mouthwash based on 0.05% cetylpyridinium chloride (CPC) (positive 
control); Group B: mouthwash based on probiotics (experimental);  Group C: 
placebo mouthwash (negative control). No oral hygiene practices or routines 
were modified; subjects were followed for 4 weeks. The primary outcome 
variable of interest was the Löe and Silness gingival index, and the secondary 
one, the Quigley Heinn plaque index modified by Turesky. Results. Of the 
45 patients included, 19 (42.2%) were men and 26 (57.7%) women, mean age 
was 22.8±2.07. Each group consisted of 15 subjects; all subjects completed the 
study. There was no statistically significant reduction in gingival inflammation 
when comparing the 3 treatment groups (p=0.540) with respect to the 
gingival index. A comparison was made before and after the treatment and 
in the 3 groups there was no reduction of the gingival inflammation. Plaque 
reduction was not statistically significant when comparing the 3 groups 
(p=0.278). However, when doing intra-group comparison, it was found that 
the patients in group A had a reduction in plaque index (p<0.005), which was 
not observed in groups B (p=0.1103) and C (p=0.1508). Conclusions. The use 
of a probiotic mouth mouthwash did not reduce gingival inflammation or the 
accumulation of dentobacterial plaque in a period of 4 weeks. There were no 
statistically significant differences between the study groups.
Keywords: Dental plaque; gingivitis; probiotics; periodontal diseases; 
mouthwashes.
INTRODUCTION.
Gingivitis is the initial stage of periodontal disease. It is related to 
a dysbiotic state of the biofilm bacteria accumulated on the dental 
surface near the gingival sulcus.1 Its main clinical manifestation 
is inflammation,2,3 which is related to an increase in the number of 
pathogenic bacteria such as Porphyromonas gingivalis, Aggregatibacter 
actinomycetemcomitans, Tannerella forsythia, although these are also 
found, in lower numbers, in healthy individuals. Given its characteristics, 
treatment based on basic cleaning and on an improvement in oral hygiene 
tend to reverse the development and progression of gingivitis before it 
causes irreversible damage.4 However, it has been reported that tooth 
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brushing alone is not completely effective to significantly 
remove the dental biofilm.5 Consequently the use of 
various antimicrobials in the form of mouthwashes, 
gels or pastes has been proposed, to complement tooth 
brushing. In this sense, cetylpyridinium chloride (CPC), 
a quaternary ammonium compound, has been clinically 
proven to be safe and effective in concentrations 0.045 
to 0.1%,6 it has a prolonged effect on the oral cavity as 
it remains attached to the glycoproteins that cover teeth 
and the oral mucosa. Some authors have shown that it 
has activity against gram positive bacteria, fungi and 
yeasts at 0.05%.7 However, eliminating both pathogenic 
and commensal bacteria with the use of antimicrobials 
perpetuates the imbalance of the oral microbiota.
New preventive and therapeutic approaches based 
on restoring the balance of the dental biofilm seem to 
be a better option.2,8 Shimauchi et al. found that the 
administration of the probiotic strain Lactobacillus 
salivarius WB21 to smokers with periodontal disease 
significantly reduced gingival sulcus depth and plaque 
index compared to a placebo group. Probiotic bacteria 
administered in sufficient quantity contribute to 
periodontal health through different mechanisms: 1) they 
interact directly with the pathogenic microbial agents 
neutralizing them, 2) they occupy niches, preventing 
colonization by pathogens, and 3) they modulate the 
inflammatory response efficiently.8-10 On the other hand, 
Alkaya et al., evaluated a mixture of the three probiotic 
strains Bacillus subtilis, Bacillus megaterium, and 
Bacillus pumulus in patients with generalized gingivitis 
and found that there was no reduction in the clinical 
parameters under study after 8 weeks of treatment.
The effectiveness of probiotics is determined by the 
bacterial strain, as well as the dose and administration 
route; for this reason, results reported in the literature 
are inconclusive. Multispecies probiotics can be a good 
alternative to recover the balance of the dental biofilm. 
The aim of this pilot study was to determine 
the clinical effect on generalized marginal chronic 
gingivitis of ProBiseisTM, a mixture  of six probiotic 
strains (Lactobacillus acidophillus, Lactobacillus casei, 
Lactobacillus rhamnosus, Lactobacillus plantarum, Bifido-
bacterium infantis and Streptococcus thermophillus) as a 
mouthwash.
MATERIALS AND METHODS.
Study design and subjects 
Randomized pilot study based on the CONSORT 
2010 guidelines extended to pilot studies.11 A population 
of 18-45 year-old subjects with a diagnosis of generalized 
marginal chronic gingivitis were included in the study. 
Subjects agreed to participate by signing an informed 
consent. They had available time, good general health 
status, no history of allergies to the components used 
in this study, were non-smokers, with 1.0 in Löe and 
Silness gingival index12 and Quingley Heinn plaque 
index modified by Turesky.13 The study was carried out 
for 4 weeks at the Periodontics Clinic of the School 
of Stomatology at Universidad Autónoma de San Luis 
Potosí (UASLP), San Luis Potosí, México. Forty-five 
subjects were included for convenience from January to 
March 2017.
Intervention
The three study groups were distributed by simple 
randomization as follows: Group A, mouthwash based 
on 0.05% CPC as a positive control (PlaxTM, Colgate 
Palmolive); Group B, mouthwash based on probiotics 
as experimental group (ProBiseisTM, Lactobacillus 
acidophillus, Lactobacillus casei, Lactobacillus rhamnosus, 
Lactobacillus plantarum, Bifidobacterium infantis, and 
Streptococcus thermophillus, Solanum laboratories); Group 
C, placebo mouthwash (saline solution with flavor). Each 
subject was instructed verbally and in writing on how to 
use the mouthwash. They were asked to use the product 
daily (Group A and C: two times a day, keeping it for 1 
minute in the mouth before spitting, after teeth brushing; 
Group B, twice a day after teeth brushing, by dissolving 
the content in 50ml of water and keeping the suspension 
for 2 minutes in mouth before spitting). Solutions and 
probiotics were provided for 15 days only, without 
displaying trademarks, in order to keep subjects blind to 
the components. No additional instructions were given 
on tooth brushing techniques or the use of toothpaste, 
nor were there restrictions on diet during the study.
Measurements
The primary and secondary output variables recorded 
were: Löe and Silness gingival index12 and Quingley 
Heinn plaque index modified by Turesky.13 The 
evaluation of clinical parameters was performed by a 
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dentist specialized in periodontics and blinded to each 
treatment group. Calibration of the evaluator was carried 
out before the study to verify the intra- and inter-examiner 
reproducibility; a correlation of 0.98 was obtained. Each 
subject completed three visits: the first one corresponded 
to day 0, informed consent was obtained, evaluation of 
the soft and hard structures of the oral cavity was carried 
out, basal measurements were made and indications 
were given. Second visit, at day 15, the content of the 
mouthwash bottles was verified to validate the use of the 
product, indications of use were repeated, any doubts 
regarding its use were resolved, and the product was given 
again for another 15 days. Third visit, at day 30, the final 
measurements of the gingival and plaque indices was 
performed. Patients were selected consecutively and for 
convenience in the period January-March of 2017.
Statistical analysis
Descriptive statistics calculations, using measures of 
central tendency for continuous variables and percentages 
for nominal variables, were performed. Normality of the 
data was checked by the D'Agostino-Pearson test and, 
according to the results, a t-paired test was used to assess 
the efficiency of the mouthwashes before and after the 
treatment. The Kruskal-Wallis test was used to evaluate 
differences between the groups; p<0.05 was considered 
statistically significant
Figure 1.  Study design and sample selection.
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Randomization
Assigned to the intervention 
(n =19 ) 
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(n = 15) 
Not received intervention
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(n = 15) 
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 (n=5)
Assigned to the intervention 
(n =20) 
Received intervention 
(n = 15) 
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 (n=5)
Lost during follow-up 
(Unable to make and attend an appointment 
due to work schedule) (n =2)
Dropped out the intervention (Medical 
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Final evaluation
(n= 15)
Final evaluation
(n= 15)
Final evaluation
(n= 15)
Follow-up
Evaluation 
Lost during follow-up 
(Never answered calls or e-mails) (n=3) 
Dropped out (Medical treatment) (n =1) 
Not full fit inclusion criteria (n=1)
Lost during follow-up (n=1) 
Dropped out (Did not attend 
final evaluation) (n =3)
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Cetylpyridinium Chloride 0.05% 
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Figure 2.  Comparison of the gingival index after 
4 weeks of intervention according to the treatment. 
Figure 3.  Comparison of the posterior plaque index after 
4 weeks of intervention according to the treatment.
p=0.540 p=0.278
2.0 2.0
1.5 1.5
1.0 1.0
0.5 0.5
0.0 0.0
FGCI FPCIFPBGI FPBPIFGPI FPPI
FGCI: final gingival cetilpiridinium index. FPBGI: final probiotic gingival index. 
FGPI: final gingival placebo index.
FPCI: positive control, final plaque cetilpiridinium index. FPBPI: final probiotic 
plate index. FPPI: negative control, final plaque placebo index.
Variable  Positive Control  Experimental Probiotic  Negative Control Total
  Cetylpyridinium (n=15) Group (n=15) Placebo (n=15)  
  N% N% N% 
Sex Male 7(15.5) 6(13.3) 6(13.3) 19(42.2)
 Female 8(17.7) 9(20.0) 9(20.0) 26(57.7)
  Med ± SD Med ± SD Med ± SD 
Age  22.6 ±2.5 22.8 ±1.6 23.07 ±2.08 22.8±2.07
Treatment IGI* (n=15) FGI&  (n=15) p<0.05+
 Med ± SD Med ± SD 
Group A (positive control) 1.18 ± 0.20 0.98 ± 0.40 p=0.11+
Group B (experimental group) 1.24 ± 0.30 1.14 ± 0.03 p=0.38+
Group C (negative control) 1.2 ± 0.20 1.08 ± 0.40 p=0.70+
Treatment IPI* (n=15) FPI&  (n=15) p<0.05+
 Med ± SD Med ± SD  
Group A (positive control) 1.38 ± 0.25 1.05 ± 0.38 p=0.009
Group B (experimental group) 1.5 ± 0.35 1.3 ± 0.42 p=0.380
Group C (negative control) 1.5 ± 0.60 1.3 ± 0.60 p=0.700
Table 1.  Demographic characteristics of the participants according to group.
Table 2.  Comparison of the initial and final gingival index in the three groups evaluated.
Table 3.  Comparison of the initial and final plaque index in the three groups evaluated.
* Initial gingival index. & Final gingival index. + t-paired. 
* Initial plaque index. & Final plaque index. + t-student test ^ U-Mann-Whitney test
RESULTS.
The total population evaluated consisted of 45 patients, 
randomization and treatment received by each group is 
shown in Figure 1. The demographic characteristics of the 
population are shown in Table 1. The baseline measurement 
of the gingival and plaque indices in the three groups 
were homogeneous; there were no statistically significant 
differences (p=0.1153, p=0.6480 respectively). None of the 
patients reported adverse effects and, likewise, no adverse 
effects were identified by the researcher at the end of the 4th 
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week of treatment.
Regarding the primary outcome variable, gingival 
inflammation, Table 2 shows the intra-group comparison, 
before and after the intervention with the different 
treatments. There was a no statistically significant difference 
in any of the groups in the reduction of the gingival index. 
However, in Group A, a gingival index reduction of 1.18 
to 0.98 was observed (p=0.112), progressing from slight 
inflammation to absence of inflammation. Figure 2 shows 
the inter-group comparison, in which group A is identified 
as having a greater reduction in the gingival index; however, 
this difference is not statistically significant with respect to 
the other treatment groups.
The intra-group comparison regarding plaque index, 
the secondary output variable, is shown in table 3, where 
it can be observed that in Group A there was a statistically 
significant reduction in the plaque index, but not in Groups 
B and C. Figure 3 shows the inter-group comparison after 
4 weeks of treatment. There was no statistically significant 
difference with respect to the reduction of the plaque index; 
however, in Group A, a greater reduction is observed in 
comparison with Groups B and C.
The treatments had a greater effect on plaque reduction 
than on reducing gingival inflammation.
DISCUSSION.
The effectiveness of probiotics use in the treatment 
of gingivitis is still debatable. Some authors support 
its effectiveness,14-16 while others have not reported 
any conclusive effects.17,18 This study evaluated the 
effectiveness of a mouthwash, ProBiseisTM, composed of six 
bacterial strains (Lactobacillus acidophillus, Lactobacillus 
casei, Lactobacillus rhamnosus, Lactobacillus plantarum, 
Bifidobacterium infantis and Streptococcus thermophillus) 
as an adjuvant treatment to the routine teeth brushing 
in patients with generalized marginal chronic gingivitis. 
The mouthwash was kept in the subjects’ mouths for only 
two minutes. For the evaluation, two widely validated 
indices were used, Löe and Silness gingival index12 and 
Quingley Heinn plaque index modified by Turesky.13 
These allowed for the degree of gingival inflammation 
and the amount of dental biofilm accumulated per 
subject to be determined, by accurately measuring its 
reduction. Regarding the primary output variable, no 
inter-group and intra-group differences were found after 
4 weeks of using the mouthwashes. 
As only patients with mild gingivitis were evaluated in 
this study, reductions in the indices are discrete; however, 
they are statistically significant for CPC regarding 
reduction of plaque, but not gingival inflammation. 
The latter may be due to the design of the study, since 
the participants’ brushing technique was not modified, 
to avoid changing their daily hygiene habits. On the 
other hand, the period of time the mouthwash was 
kept in mouth may not have been sufficient to achieve 
an adequate colonization. Likewise the length of the 
intervention may have not been enough (4 weeks), since 
reduction in gingival inflammation has been reported 
after using probiotics for 8 weeks.15 To remedy these 
limitations, there are plans to conduct this study for 
a longer period of time. Another factor that may have 
influenced results was the use of mouthwashes. Subjects 
were instructed about their administration at the 
beginning of the study. 
Then it was corroborated that the containers were 
empty when they came back for the checkup. Then the 
product was restocked, however, it is difficult to ascertain 
if the subjects followed the instructions correctly. The 
probiotic mouthwash used in this study did not reduce 
mild chronic marginal gingivitis or the associated 
dental biofilm. However, it is important to consider 
other studies where its efficacy has been demonstrated 
in the treatment of severe gingivitis.14 The effectiveness 
of probiotic strains could be due to the prevention 
of pathogenic bacteria from adhering to dental and 
gingival surfaces. In addition, these strains modify 
the composition of salivary proteins, balance the oral 
pH and improve the expression of helper T cells.21 The 
expected outcome was not reached due to the following 
factors: a) the probiotic strain(s) used; b) the dose or 
concentration of these, c) the administration route and 
form of application, and d) the length of administration.
Although the use of probiotics has increased in 
recent years and several lines of research have been 
generated, in Mexico there are not enough commercially 
available options, either in the form of chewable tablets, 
mouthwashes or gels. In addition, there are no studies 
evaluating the effect of specific species or bacterial 
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mixtures in the Mexican population. Therefore it was 
considered that it would be a contribution to evaluate 
the mixture of probiotic strains present in ProBiseisTM, 
dissolved in running water and used as mouthwash 
twice a day and kept in the mouth for 2 minutes in a 
similar way to commercial antimicrobial mouthwashes. 
Few authors have conducted similar studies so literature 
regarding this protocol is scarse.18
It is important to evaluate in clinical trials new and 
better probiotic strains isolated from the oral cavity, 
different means and alternatives to achieve appropriate 
contact time so they become active in saliva and on 
the structures of the mouth. A product containing oral 
probiotic strains may have better results in maintaining 
or restoring the balance of the dental biofilm, since 
the effect of probiotics is niche- and species-specific 
as demonstrated by Shimauchi et al.,16 these authors 
studied patients with moderate to severe gingivitis, 
who were given tablets of Lactobacillus salivarius WB21 
for 8 weeks, 3 times a day. After the trial, patients had 
achieved a reduction in periodontal pocket depth, clinical 
insertion level and in dental biofilm. Krasse et al.,15 also 
reported a reduction in the level of inflammation and 
dental biofilm using L. reuteri (LR-1 or LR-2) in patients 
with moderate to severe gingivitis.
In 2011 Montero  et al.,17  reported the use of probiotics 
in dentistry stating that, despite the limitations of existing 
studies, clinical results seem to be more limited than 
laboratory microbiological results. Based on the above, 
it is possible to state that probiotics may be potentially 
beneficial as adjuvant therapy to periodontal treatment; 
however, the information resulting from clinical trials 
so far is limited to support this. On the other hand, 
some authors, such as Inesta et al.,22 reported not having 
observed clinical changes in patients or in bacteriological 
samples between groups, using Lactobacillus reuteri and 
Lactobacillus salivarius against a placebo during a period 
of 8 weeks, partially agreeing with the results obtained 
in this study.         
Finally, a reduction in gingival inflammation and 
biofilm formation in the placebo group was not observed, 
which indicates that the tooth brushing technique used 
by the subjects was not adequate, as it did not remove 
dental biofilm nor reduce gingival inflammation.
For the secondary output variable intra-group 
differences were evident in Group A, and based on the 
results obtained, the 0.05% CPC mouthwash used as 
a positive control significantly reduced dental biofilm, 
which agrees with the findings of Kozak et al.,19 They 
reported a reduction in plaque accumulation of 55% 
when using a 0.05% CPC mouthwash + routine brushing 
compared to tooth brushing alone.  Costa et al.,6 on the 
other hand, found that CPC mouthwash at 0.05% and 
0.07% have been shown to be safe and effective, with 
virtually no adverse effects, raising the possibility of 
using these routinely, making it the ideal product to use 
as a positive control.20
One of the limitations of this study is the fact that it 
is not possible to make an analysis with greater precision 
since previous clinical studies evaluating multispecies 
probiotic mixtures have not been reported in the 
literature. 
For that reason, this was considered a pilot study, 
with the aim of determining its feasibility and being 
able to later conduct an RCT. However, to demonstrate 
the effectiveness of this probiotic mixture based on 
observations that have been made in previous studies, 
253 subjects per group are required to find statistically 
significant differences.18 
Other possible limitations were that patients with 
mild gingivitis were included, the length of time that 
the mouthwash was used (2 minutes), as well as the 
duration of the intervention. For these reasons the 
evaluation of the same mixture of probiotics is planned, 
and measuring its impact in the periodontal treatment 
of patients with moderate to severe gingivitis, increasing 
the length of exposure to the probiotic in the mouth 
using, for example, a chewable pill or candy lollipop for 
8 weeks.
CONCLUSION.
A mouthwash containg the probiotic strains: Lacto-
bacillus acidophillus, Lactobacillus casei, Lactobacillus 
rhamnosus, Lactobacillus plantarum, Bifidobacterium 
infantis and Streptococcus thermophius, did not reduce 
gingival inflammation or the accumulation of dental 
plaque in a period of 4 weeks. There were no statistically 
significant differences between the groups under study.
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